Quantcast

Case activity for Carrie Deselms vs Teva Pharmaceuticals USA Inc. on Sept. 4

PENNSYLVANIA RECORD

Tuesday, April 1, 2025

Case activity for Carrie Deselms vs Teva Pharmaceuticals USA Inc. on Sept. 4

Filings
Webp general court 09

shutterstock.com

The U.S. District Court for the Eastern District of Pennsylvania reported the following activities in the suit brought by Carrie Deselms against Coopersurgical Inc.,, Duramed Pharmaceuticals Inc., a Division of Barr Pharmaceuticals, INC., D B a Teva Women's Health, INC.,, THE Cooper Companies Inc.,, Teva Pharmaceuticals USA Inc., Teva Women's Health Inc., Individually, and, Teva Women's Health LLC F K a Teva Women's Health, Inc. and Teva Women's Health LLC, Individually and on Sept. 4.

'Notice Of Removal By The Cooper Companies, Inc.,, Teva Women's Health, Llc., Individually And As Successor In Interest To Teva Women's Health, Inc., Coopersurgical, Inc.,, Teva Pharmaceuticals Usa, Inc., Teva Women's Health, Inc., Individually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc., A Division Of Barr Pharmaceuticals, Inc., (filing Fee $ 400 Receipt Number 0313-14544409), Filed By The Cooper Companies, Inc.,, Teva Women's Health, Llc., Individually And As Successor In Interest To Teva Women's Health, Inc., Coopersurgical, Inc.,, Teva Pharmaceuticals Usa, Inc., Teva Women's Health, Inc., Individually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc., A Division Of Barr Pharmaceuticals, Inc.,.(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 By Teva Pharmaceuticals Usa, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 By Teva Women's Health, Inc., Individually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc., A Division Of Barr Pharmaceuticals, Inc.,.(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 By Teva Women's Health, Llc., Individually And As Successor In Interest To Teva Women's Health, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 By Coopersurgical, Inc.,.(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 By The Cooper Companies, Inc.,.(rubenstein, Brian)'

'Answer To Complaint By Teva Pharmaceuticals Usa, Inc..(rubenstein, Brian)'

'Answer To Complaint By Teva Women's Health, Inc., Individually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc., A Division Of Barr Pharmaceuticals, Inc.,.(rubenstein, Brian)'

'Answer To Complaint By Teva Women's Health, Llc., Individually And As Successor In Interest To Teva Women's Health, Inc..(rubenstein, Brian)'

'Answer To Complaint By Coopersurgical, Inc.,.(rubenstein, Brian)'

'Answer To Complaint By The Cooper Companies, Inc.,.(rubenstein, Brian)'

Case number 2:20-cv-04350 was filed in the U.S. District Court for the Eastern District of Pennsylvania on Sept. 4.

More News